Documents

Q2 delivered strong organic growth, margin expansion, and raised full-year guidance to 5%.

Synergy targets, media focus, and AI-driven Omni platform drive growth and client ROI.

Director elections, executive pay, and auditor ratification all passed with strong shareholder support.

Strong Q1 growth, margin expansion, and integration synergies drive double-digit EPS outlook.

Data-driven integration and AI power growth, with 2026 double-digit EPS and $1.5B synergies targeted.

2026 Incentive Award Plan approved by majority vote with 85% shareholder participation.

Closed IPG deal, realigned portfolio, targeting $1.5B synergies and strong Media-led growth.

Q3 saw 2.6% organic growth, strong media gains, and Interpublic deal closing expected in November.

Q2 organic growth hit 3%, Media led gains, and IPG deal remains on track for H2 close.

IPG integration accelerates with $750M synergy target, robust outlook for precision marketing and healthcare.

Q1 organic revenue up 3.4%, margin steady, Interpublic deal on track, outlook cautious.

Acquisition and integration plans drive growth, with AI and data platforms fueling client wins.